bioAffinity Technologies (BIAF) vs ENDRA Life Sciences (NDRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
ENDRA Life Sciences is the larger company by market cap ($8.9 million vs $6.6 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BIAF | NDRA |
|---|---|---|
| Share price | $5.64 | $5.93 |
| Market cap | $6.58M | $8.89M |
| 1-day change | -8.44% | -2.15% |
| EPS (TTM) | $-109.35 | $-6.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $80.70 | $9.85 |
| 52-week low | $4.56 | $2.96 |
| Distance from 52-week high | -93.01% | -39.80% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +321.59% |
| Average volume | 3.67M | 34.65K |
| Shares outstanding | 1.17M | 1.50M |
| Employees | 57 | 9 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About bioAffinity Technologies
BIAF stock →bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 57 employees
About ENDRA Life Sciences
NDRA stock →ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 9 employees
BIAF vs NDRA FAQ
Which is bigger, bioAffinity Technologies or ENDRA Life Sciences?
ENDRA Life Sciences (NDRA) is larger, with a market capitalization of $8.89M compared with $6.58M for bioAffinity Technologies (BIAF).
Are bioAffinity Technologies and ENDRA Life Sciences in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Commercial Physical & Biological Resarch for bioAffinity Technologies and Biotechnology: Electromedical & Electrotherapeutic Apparatus for ENDRA Life Sciences.